logo
Exercise helps maintain vitamin D levels in winter without supplements

Exercise helps maintain vitamin D levels in winter without supplements

Glasgow Times14-05-2025

Regular, moderate-intensity exercise helps maintain crucial vitamin D levels during the darker months – even without weight loss or supplements.
Researchers found that overweight and obese adults who completed a 10-week indoor exercise programme over winter experienced significantly smaller drops in vitamin D levels compared with those who did not exercise, even though their body weight was deliberately maintained.
More than 50 people took part in four sessions per week of two treadmill walks, one longer steady-state bike ride, and one high-intensity interval bike session.
Exercise helps maintain vitamin D levels in winter without supplements, according to scientists (James Manning/PA)
Exercise completely preserved the body's active form of vitamin D, which plays a key role in supporting bone health, the immune system, and various organs.
Previous studies suggest that vitamin D supplements alone do not help maintain this active form.
The small-scale study was led by academics from the University of Bath, University of Birmingham and University of Cambridge.
Lead author Dr Oly Perkin, from the University of Bath, said: 'This is the first study to show that exercise alone can protect against the winter dip in vitamin D.
'It's a powerful reminder that we still have lots to learn about how exercise benefits our health.'
People who exercised saw a smaller drop in their overall vitamin D levels over winter of around 15%, compared with a 25% drop in those who did not exercise.
Those who exercised kept healthy levels of the active form of vitamin D, which helps support the immune system and bone health.
In the non-exercising group, levels of this active form fell by 15%.
Weight was kept stable throughout the study, proving the effect was due to exercise, not weight loss.
To ensure sunlight did not skew results, the study ran between October and April – when natural vitamin D production from sunlight is minimal in this part of the UK – and participants were asked to avoid supplements.
A previous study from the team showed that a single workout can briefly boost vitamin D levels, but this is the first to show that regular cardio exercise can maintain basal circulating vitamin D levels and offer lasting protection during the winter months.
Principal investigator Professor Dylan Thompson, from the University of Bath, said: 'Collectively, the findings from the VitaDEx project show that exercise increases the concentrations of vitamin D metabolites each time you are active and, on top of this, doing regular activity helps to maintain your basal resting levels of vitamin D during winter.
'This means exercise gives you a double benefit to your vitamin D, first in and around each exercise bout, and second through changing your baseline levels.'
The study offers compelling evidence that exercise could be an effective winter vitamin D strategy, especially for those who are overweight or obese for whom vitamin D supplements are less effective.
Liam Kilawee, who took part in the study, said: 'I was impressed on how thorough the process was and how the team engaged with me during research period.
'The results were pleasing as I could see that my actions had a positive reaction.'
– The study, Exercise without Weight Loss Prevents Seasonal Decline in Vitamin D Metabolites: The VitaDEx Randomised Controlled Trial, is published in the journal Advanced Science.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Women taking weight-loss jabs warned they must use effective contraception
Women taking weight-loss jabs warned they must use effective contraception

STV News

time30 minutes ago

  • STV News

Women taking weight-loss jabs warned they must use effective contraception

Women taking weight-loss jabs are being warned they must use effective contraception. The Medicines and Healthcare products Regulatory Agency (MHRA) issued its first alert to the public regarding contraception and weight loss and diabetes jabs following concerns they may not be used safely. The injections have been previously linked to a 'baby boom', with women reporting online that they have had surprise 'Ozempic babies' despite using contraception. To date, the MHRA has received more than 40 reports relating to pregnancy among women on the drugs. There are also warnings over a lack of evidence for pregnancy safety for the jabs, which include Ozempic, Mounjaro, Wegovy, Saxenda and Victoza. The MHRA said the drugs – which are glucagon-like peptide-1 receptor agonists (GLP-1 or GLP-1 RAs) – must not be taken during pregnancy, while trying to get pregnant, or during breastfeeding. Anyone who gets pregnant while using the drugs should also stop taking the medicine, it added. It said: 'This is because there is not enough safety data to know whether taking the medicine could cause harm to the baby.' In some cases, women are also advised to continue using contraception for up to two months between stopping the medicine and trying to get pregnant. The MHRA said effective contraception includes the oral contraceptive pill, contraceptive implants, the coil and condoms. Those patients taking Mounjaro – which may reduce the effectiveness of oral contraceptives in people who are overweight – should also use condoms if they are on the pill. The MHRA said: 'This only applies to those taking Mounjaro and is especially important for the four weeks after starting Mounjaro and after any dose increase.' The advice on contraception is also contained in patient information leaflets that come with the medicines. MHRA data shared with by the PA news agency shows it has received 27 pregnancy-related reports for Mounjaro. It is not necessary for women to say whether the pregnancy was unintentional, though one report did say the pregnancy was such. There have been a further eight reports relating to pregnancy in people taking semaglutide (the ingredient in Ozempic and Wegovy). A further nine have been recorded for liraglutide (Victoza or Saxenda), of which one recorded the pregnancy was unintentional. A further nine have been recorded for liraglutide (Victoza or Saxenda), of which one recorded the pregnancy was unintentional. The MHRA is also reminding people that weight-loss jabs should not be bought from unregulated sellers such as beauty salons or via social media, or taken without speaking to a health professional. Anyone who suspects they have had an adverse reaction or suspects their drug is not a genuine product, should report it to the MHRA Yellow Card scheme. Dr Alison Cave, MHRA chief safety officer, said: 'Skinny jabs are medicines licensed to treat specific medical conditions and should not be used as aesthetic or cosmetic treatments. 'They are not a quick fix to lose weight and have not been assessed to be safe when used in this way. 'Our guidance offers patients a 'one-stop shop' for our up-to-date advice on how to use these powerful medicines safely. 'This guidance should not be used as a substitute to reading the patient information leaflet or having a conversation with a healthcare professional as part of the prescribing process.' The latest guidance also reminds patients taking jabs of the symptoms to look out for in the event of acute pancreatitis which, although uncommon, can be serious. The main symptom is severe pain in the stomach that radiates to the back and does not go away, and people should seek immediate medical help. GLP-1 or GLP-1 RAs help people feel fuller by mimicking a natural hormone released after eating. Some, like Mounjaro, also act on a second hormone involved in appetite and blood sugar control. Jasmine Shah, medication safety officer at the National Pharmacy Association, said: 'Pharmacists urge women taking GLP-1 medicines to note this important new guidance from the MHRA published today and use effective contraception. 'Community pharmacies have been experiencing unprecedented levels of interest for weight loss injections. 'It is therefore important that regulations and guidance keep pace with this demand and that patient safety is put at the heart of everything we do. 'Medicines are not like ordinary goods for sale; they must be handled with great care because they have the power to harm as well as to heal. 'We also reiterate warnings from the MHRA to avoid any potential fake weight loss injections sold on social media or via beauty salons, which could pose a serious risk to someone's health. 'We urge anyone who have concerns about this medication to speak to their pharmacist for advice.' Get all the latest news from around the country Follow STV News Scan the QR code on your mobile device for all the latest news from around the country

Women taking weight-loss jabs warned they must use effective contraception
Women taking weight-loss jabs warned they must use effective contraception

Glasgow Times

time32 minutes ago

  • Glasgow Times

Women taking weight-loss jabs warned they must use effective contraception

The Medicines and Healthcare products Regulatory Agency (MHRA) issued its first alert to the public regarding contraception and weight loss and diabetes jabs following concerns they may not be used safely. The injections have been previously linked to a 'baby boom', with women reporting online that they have had surprise 'Ozempic babies' despite using contraception. To date, the MHRA has received more than 40 reports relating to pregnancy among women on the drugs. There are also warnings over a lack of evidence for pregnancy safety for the jabs, which include Ozempic, Mounjaro, Wegovy, Saxenda and Victoza. The MHRA said the drugs – which are glucagon-like peptide-1 receptor agonists (GLP-1 or GLP-1 RAs) – must not be taken during pregnancy, while trying to get pregnant, or during breastfeeding. Anyone who gets pregnant while using the drugs should also stop taking the medicine, it added. It said: 'This is because there is not enough safety data to know whether taking the medicine could cause harm to the baby.' In some cases, women are also advised to continue using contraception for up to two months between stopping the medicine and trying to get pregnant. The MHRA said effective contraception includes the oral contraceptive pill, contraceptive implants, the coil and condoms. Those patients taking Mounjaro – which may reduce the effectiveness of oral contraceptives in people who are overweight – should also use condoms if they are on the pill. The MHRA said: 'This only applies to those taking Mounjaro and is especially important for the four weeks after starting Mounjaro and after any dose increase.' The advice on contraception is also contained in patient information leaflets that come with the medicines. MHRA data shared with by the PA news agency shows it has received 26 pregnancy-related reports for Mounjaro. It is not necessary for women to say whether the pregnancy was unintentional, though one report did say the pregnancy was such. There have been a further eight reports relating to pregnancy in people taking semaglutide (the ingredient in Ozempic and Wegovy). A further nine have been recorded for liraglutide (Victoza or Saxenda), of which one recorded the pregnancy was unintentional. The MHRA is also reminding people that weight-loss jabs should not be bought from unregulated sellers such as beauty salons or via social media, or taken without speaking to a health professional. Anyone who suspects they have had an adverse reaction or suspects their drug is not a genuine product, should report it to the MHRA Yellow Card scheme. Dr Alison Cave, MHRA chief safety officer, said: 'Skinny jabs are medicines licensed to treat specific medical conditions and should not be used as aesthetic or cosmetic treatments. 'They are not a quick fix to lose weight and have not been assessed to be safe when used in this way. 'Our guidance offers patients a 'one-stop shop' for our up-to-date advice on how to use these powerful medicines safely. 'This guidance should not be used as a substitute to reading the patient information leaflet or having a conversation with a healthcare professional as part of the prescribing process.' The latest guidance also reminds patients taking jabs of the symptoms to look out for in the event of acute pancreatitis which, although uncommon, can be serious. The main symptom is severe pain in the stomach that radiates to the back and does not go away, and people should seek immediate medical help. GLP-1 or GLP-1 RAs help people feel fuller by mimicking a natural hormone released after eating. Some, like Mounjaro, also act on a second hormone involved in appetite and blood sugar control. Jasmine Shah, medication safety officer at the National Pharmacy Association, said: 'Pharmacists urge women taking GLP-1 medicines to note this important new guidance from the MHRA published today and use effective contraception. 'Community pharmacies have been experiencing unprecedented levels of interest for weight loss injections. 'It is therefore important that regulations and guidance keep pace with this demand and that patient safety is put at the heart of everything we do. 'Medicines are not like ordinary goods for sale; they must be handled with great care because they have the power to harm as well as to heal. 'We also reiterate warnings from the MHRA to avoid any potential fake weight loss injections sold on social media or via beauty salons, which could pose a serious risk to someone's health. 'We urge anyone who have concerns about this medication to speak to their pharmacist for advice.'

Women taking weight-loss jabs warned they must use effective contraception
Women taking weight-loss jabs warned they must use effective contraception

South Wales Guardian

time6 hours ago

  • South Wales Guardian

Women taking weight-loss jabs warned they must use effective contraception

The Medicines and Healthcare products Regulatory Agency (MHRA) issued its first alert to the public regarding contraception and weight loss and diabetes jabs following concerns they may not be used safely. The injections have been previously linked to a 'baby boom', with women reporting online that they have had surprise 'Ozempic babies' despite using contraception. To date, the MHRA has received more than 40 reports relating to pregnancy among women on the drugs. There are also warnings over a lack of evidence for pregnancy safety for the jabs, which include Ozempic, Mounjaro, Wegovy, Saxenda and Victoza. The MHRA said the drugs – which are glucagon-like peptide-1 receptor agonists (GLP-1 or GLP-1 RAs) – must not be taken during pregnancy, while trying to get pregnant, or during breastfeeding. Anyone who gets pregnant while using the drugs should also stop taking the medicine, it added. It said: 'This is because there is not enough safety data to know whether taking the medicine could cause harm to the baby.' In some cases, women are also advised to continue using contraception for up to two months between stopping the medicine and trying to get pregnant. The MHRA said effective contraception includes the oral contraceptive pill, contraceptive implants, the coil and condoms. Those patients taking Mounjaro – which may reduce the effectiveness of oral contraceptives in people who are overweight – should also use condoms if they are on the pill. The MHRA said: 'This only applies to those taking Mounjaro and is especially important for the four weeks after starting Mounjaro and after any dose increase.' The advice on contraception is also contained in patient information leaflets that come with the medicines. MHRA data shared with by the PA news agency shows it has received 26 pregnancy-related reports for Mounjaro. It is not necessary for women to say whether the pregnancy was unintentional, though one report did say the pregnancy was such. There have been a further eight reports relating to pregnancy in people taking semaglutide (the ingredient in Ozempic and Wegovy). A further nine have been recorded for liraglutide (Victoza or Saxenda), of which one recorded the pregnancy was unintentional. The MHRA is also reminding people that weight-loss jabs should not be bought from unregulated sellers such as beauty salons or via social media, or taken without speaking to a health professional. Anyone who suspects they have had an adverse reaction or suspects their drug is not a genuine product, should report it to the MHRA Yellow Card scheme. Dr Alison Cave, MHRA chief safety officer, said: 'Skinny jabs are medicines licensed to treat specific medical conditions and should not be used as aesthetic or cosmetic treatments. 'They are not a quick fix to lose weight and have not been assessed to be safe when used in this way. 'Our guidance offers patients a 'one-stop shop' for our up-to-date advice on how to use these powerful medicines safely. 'This guidance should not be used as a substitute to reading the patient information leaflet or having a conversation with a healthcare professional as part of the prescribing process.' The latest guidance also reminds patients taking jabs of the symptoms to look out for in the event of acute pancreatitis which, although uncommon, can be serious. The main symptom is severe pain in the stomach that radiates to the back and does not go away, and people should seek immediate medical help. GLP-1 or GLP-1 RAs help people feel fuller by mimicking a natural hormone released after eating. Some, like Mounjaro, also act on a second hormone involved in appetite and blood sugar control. Jasmine Shah, medication safety officer at the National Pharmacy Association, said: 'Pharmacists urge women taking GLP-1 medicines to note this important new guidance from the MHRA published today and use effective contraception. 'Community pharmacies have been experiencing unprecedented levels of interest for weight loss injections. 'It is therefore important that regulations and guidance keep pace with this demand and that patient safety is put at the heart of everything we do. 'Medicines are not like ordinary goods for sale; they must be handled with great care because they have the power to harm as well as to heal. 'We also reiterate warnings from the MHRA to avoid any potential fake weight loss injections sold on social media or via beauty salons, which could pose a serious risk to someone's health. 'We urge anyone who have concerns about this medication to speak to their pharmacist for advice.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store